Zofran ODT is an orally disintegrating tablet formulation of ondansetron, an antiemetic medication [1]. It is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery [1]. The orally disintegrating tablet (ODT) form dissolves on the tongue, allowing for administration without water [1].
What is ondansetron used for?
Ondansetron, the active ingredient in Zofran ODT, is a serotonin 5-HT3 receptor antagonist [1]. It works by blocking the action of serotonin, a substance in the body that can cause nausea and vomiting [1]. This makes it effective in managing chemotherapy-induced nausea and vomiting (CINV) and post-operative nausea and vomiting (PONV) [1].
How does Zofran ODT work compared to other antiemetics?
Zofran ODT's mechanism of action, blocking serotonin 5-HT3 receptors, is a primary approach for managing CINV and PONV [1]. Other antiemetics may target different pathways. For example, dopamine antagonists or corticosteroids are also used in antiemetic regimens, sometimes in combination with 5-HT3 antagonists to provide broader coverage for different types and timings of nausea and vomiting [2]. The ODT formulation offers a convenience advantage for patients who have difficulty swallowing pills or are experiencing severe nausea [1].
When does the patent for Zofran expire?
The original patents for ondansetron have long since expired, allowing for the availability of generic versions [3]. DrugPatentWatch.com tracks patent information, and for ondansetron, the primary composition of matter patents have expired [3]. This means that generic manufacturers can produce and market ondansetron, including orally disintegrating formulations [3].
Who manufactures Zofran ODT?
Originally, Zofran was developed and marketed by GlaxoSmithKline (GSK) [4]. Following patent expirations, generic versions of ondansetron ODT are manufactured by various pharmaceutical companies [3].
What are the side effects of Zofran ODT?
Common side effects of Zofran ODT can include headache, constipation, diarrhea, dizziness, and fatigue [1]. Less common but more serious side effects may involve changes in heart rhythm, particularly QT prolongation, and allergic reactions [1]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there alternatives to Zofran ODT?
Yes, alternatives to Zofran ODT exist, both in terms of different formulations of ondansetron and entirely different classes of antiemetic drugs [2]. Other 5-HT3 receptor antagonists such as granisetron or palonosetron are available [2]. Additionally, other drug classes like NK-1 receptor antagonists (e.g., aprepitant), corticosteroids (e.g., dexamethasone), and dopamine antagonists (e.g., prochlorperazine) are used for nausea and vomiting, often as part of combination therapy [2]. The choice of alternative depends on the specific cause of nausea and vomiting and the patient's individual needs and medical history.
What is the cost of Zofran ODT?
The cost of Zofran ODT can vary significantly depending on whether a brand-name or generic product is purchased, insurance coverage, and pharmacy pricing [3]. Generic versions of ondansetron ODT are generally more affordable than the brand-name Zofran ODT due to market competition [3].
What clinical data supports Zofran ODT's use?
Extensive clinical trials have demonstrated the efficacy of ondansetron in reducing nausea and vomiting associated with chemotherapy and radiotherapy [1]. Studies comparing ondansetron to placebo and other antiemetics have established its effectiveness, leading to its widespread use in oncology and post-operative care [1]. The orally disintegrating formulation has also been studied to confirm its bioequivalence and patient acceptance compared to conventional tablets [1].
Can generic ondansetron ODT be as effective as brand-name Zofran ODT?
Generic medications are required to meet the same standards of quality, safety, and efficacy as their brand-name counterparts [4]. Generic ondansetron ODT products are considered bioequivalent to brand-name Zofran ODT, meaning they are absorbed into the bloodstream at the same rate and extent [1, 4]. Therefore, generic versions are expected to be therapeutically equivalent.
Sources:
[1] https://www.drugs.com/zofran-odt.html
[2] https://www.cancer.gov/about-cancer/treatment/side-effects/nausea
[3] https://www.drugpatentwatch.com/
[4] https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019603s040lbl.pdf